Alector, Inc. (ALEC)

↓ Download CSV

CIK 0001653087 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, Alector, Inc. reported revenue of $21.05M, down 79.1% from the prior year. The company ran a net loss, with a net margin of -679.2%. It held $293.24M in total assets against $262.59M in total liabilities.

Key ratios (FY2025)

-741.3%
Operating margin
-679.2%
Net margin
-466.3%
Return on equity
-79.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$21.05M$100.56M$97.06M$133.62M$207.09M$21.10M$21.22M$27.51M$2.87M
Operating Income-$156.01M-$145.00M-$151.74M-$137.83M-$37.36M-$195.17M-$114.40M-$57.29M-$32.68M
Net Income-$142.93M-$119.05M-$130.39M-$133.31M-$36.33M-$190.23M-$105.39M-$52.25M-$32.48M
EPS (Diluted)$-1.39$-1.23$-1.56$-1.62$-0.45$-2.45
Total Assets$293.24M$468.30M$621.83M$787.65M$814.66M$488.25M$421.91M$308.36M
Total Liabilities$262.59M$341.50M$487.67M$573.21M$513.93M$220.72M$227.17M$195.24M
Shareholders' Equity$30.65M$126.80M$134.16M$214.44M$300.72M$267.53M$194.74M-$97.40M-$52.03M-$24.91M
Cash & Equivalents$65.80M$33.02M$74.56M$154.32M$329.15M$49.97M$89.64M$65.47M$32.45M
Operating Cash Flow-$184.03M-$229.91M-$184.16M-$20.33M$298.55M-$166.73M-$99.31M$127.46M-$17.77M
Capital Expenditures$41.0K$1.25M$2.38M$4.12M$3.25M$5.03M$15.27M$1.88M$801.0K
Shares Outstanding110.36M99.09M84.88M82.90M81.99M79.32M69.05M13.76M